InnoPharm Ltd. Announces Commercial Launch of Acamprosate Delayed-Release Tablets in the United States
8/15/2013 9:51:02 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
PISCATAWAY, NJ, Aug. 15, 2013 (GLOBE NEWSWIRE) -- InnoPharma, Inc. today announced the launch of acamprosate calcium, 333 mg delayed-release tablets (generic equivalent of Campral®). InnoPharma developed the generic formulation of acamprosate delayed-release tablets and entered into an agreement with Glenmark Pharmaceuticals, Inc. pursuant to which Glenmark will sell, market and distribute acamprosate in the United States.
Help employers find you! Check out all the jobs and post your resume.
comments powered by